‘Resilient’ Pacific Edge announces capital raise
Cancer diagnostics company Pacific Edge has announced a $20 million capital raise in tandem with what it describes as a "resilient" full-year financial result.
SUBSCRIBER
SUBSCRIBER
SUBSCRIBER
SUBSCRIBER
SUBSCRIBER
SUBSCRIBER
SUBSCRIBER
SUBSCRIBER
SUBSCRIBER
SUBSCRIBER
SUBSCRIBER
SUBSCRIBER